Motilin (26-47), human, porcine is an endogenous motilin receptor ligand with Ki and EC50 of 2.3 nM and 0.3 nM in a Chinese hamster ovary cell line.
CAT No: R1516
CAS No: 52906-92-0
Synonyms/Alias: 52906-92-0;Motilin (26-47), human, porcine;MOTILIN;CHEMBL411576;PML-4147-V;BDBM50143037;DA-55645;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C120H188N34O35S |
M.W/Mr. | 2699.1 |
Sequence | One Letter Code:FVPXFXYGELQRMQEKERNKGQ Three Letter Code:H-DL-Phe-DL-Val-DL-Pro-DL-xiIle-DL-Phe-DL-xiThr-DL-Tyr-Gly-DL-Glu-DL-Leu-DL-Gln-DL-Arg-DL-Met-DL-Gln-DL-Glu-DL-Lys-DL-Glu-DL-Arg-DL-Asn-DL-Lys-Gly-DL-Gln-OH |
Application | Endogenous motilin receptor ligand (Ki = 2.3 nM) that regulates gastrointestinal motor function. Stimulates contraction of gut smooth muscle (EC50 = 1 nM) and increases pepsin release. |
InChI | InChI=1S/C120H188N34O35S/c1-9-64(6)97(152-114(184)86-31-22-53-154(86)117(187)96(63(4)5)151-99(169)70(123)56-66-23-12-10-13-24-66)115(185)150-84(57-67-25-14-11-15-26-67)113(183)153-98(65(7)155)116(186)149-83(58-68-32-34-69(156)35-33-68)101(171)135-60-91(161)136-75(39-45-93(163)164)105(175)147-82(55-62(2)3)111(181)145-77(37-43-88(125)158)106(176)140-73(29-20-51-132-119(128)129)103(173)146-80(48-54-190-8)110(180)142-76(36-42-87(124)157)107(177)144-79(41-47-95(167)168)108(178)139-72(28-17-19-50-122)102(172)143-78(40-46-94(165)166)109(179)141-74(30-21-52-133-120(130)131)104(174)148-85(59-90(127)160)112(182)138-71(27-16-18-49-121)100(170)134-61-92(162)137-81(118(188)189)38-44-89(126)159/h10-15,23-26,32-35,62-65,70-86,96-98,155-156H,9,16-22,27-31,36-61,121-123H2,1-8H3,(H2,124,157)(H2,125,158)(H2,126,159)(H2,127,160)(H,134,170)(H,135,171)(H,136,161)(H,137,162)(H,138,182)(H,139,178)(H,140,176)(H,141,179)(H,142,180)(H,143,172)(H,144,177)(H,145,181)(H,146,173)(H,147,175)(H,148,174)(H,149,186)(H,150,185)(H,151,169)(H,152,184)(H,153,183)(H,163,164)(H,165,166)(H,167,168)(H,188,189)(H4,128,129,132)(H4,130,131,133) |
InChI Key | LVRVABPNVHYXRT-UHFFFAOYSA-N |
1. Emu oil in combination with other active ingredients for treating skin imperfections
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.